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Activation of an initiator caspase is essential to the execution of
apoptosis. The molecular mechanisms by which initiator caspases
are activated remain poorly understood. Here we demonstrate that
the autocatalytic cleavage of Dronc, an important initiator caspase
inDrosophila, results in a drastic enhancement of its catalytic activ-
ity in vitro. The autocleavedDronc forms ahomodimer,whereas the
uncleaved Dronc zymogen exists exclusively as a monomer. Thus
the autocatalytic cleavage in Dronc induces its stable dimerization,
which presumably allows the two adjacent monomers to mutually
stabilize their active sites, leading to activation. Crystal structure of
a prodomain-deleted Dronc zymogen, determined at 2.5 A˚ resolu-
tion, reveals an unproductive conformation at the active site, which
is consistent with the observation that the zymogen remains cata-
lytically inactive. This study revealed insights into mechanism of
Dronc activation, and in conjunction with other observations, sug-
gests diverse mechanisms for the activation of initiator caspases.
Caspases, the executioners of cell death, comprise two families, the
initiator caspases and the effector caspases (1, 2). Caspase is synthesized
as a single-chain zymogen and must undergo an activation process to
acquire full catalytic activity. An effector caspase is activated through an
intrachain cleavage mediated by a specific initiator caspase. For exam-
ple, the effector caspase-3 and caspase-7 are processed by the initiator
caspase-9 in the intrinsic apoptosis pathway or by the initiator caspase-8
in the extrinsic pathway (2, 3). An initiator caspase, on the other hand, is
autoactivated in response to upstreamdeath stimuli. The autoactivation
of an initiator caspase is mediated by a specific adaptor protein complex
in cells.
The activationmechanism for the effector caspases, as exemplified by
caspase-7 (4, 5), is well characterized. Both the zymogen and the active
formof caspase-7 are constitutively homodimeric. The active site of one
caspase-7 monomer is formed by five surface loops: four from within,
named L1, L2, L3, and L4, and the fifth one from the adjacentmonomer,
named L2. This structural feature necessitates dimerization for activa-
tion of the effector caspases. In the caspase-7 zymogen, the L2 loop is
covalently linked to its N-terminal sequences and is unable to adopt the
conformation as required in the activated caspase-7. Consequently, the
active site of the caspase-7 zymogen adopts an inactive conformation
that does not support catalysis. The intrachain cleavage of caspase-7
zymogen allows the L2 loop to adopt the correct conformation.
In contrast to effector caspases, the mechanisms of activation for the
initiator caspases are poorly understood (6). One of the most intensely
studied initiator caspases is caspase-9, the activation of which requires
the assembly of the apoptosome, a 1-MDa protein complex composed
of Apaf-1, cytochrome c, and ATP/dATP (7). Interestingly, the auto-
cleaved caspase-9 remains associated with the apoptosome as an active
holoenzyme, and the isolated, cleaved caspase-9 is marginally active (8).
The prodomain of caspase-9, which is not cleaved off the caspase unit in
the activated enzyme, is primarily responsible for binding to Apaf-1.
Both the zymogen and themature caspase-9 exist as amonomer (9), and
the autocatalytic cleavage does not play a critical role in the activation of
caspase-9 (10). Despite recent progress (11, 12), the underlying mecha-
nism by which the apoptosome activates caspase-9 remains enigmatic.
In contrast to caspase-9, autocatalytic cleavage appears to play an essen-
tial role for the activation of caspase-8 (13, 14) and caspase-2 (15). In
both cases, the autocatalytic cleavage facilitates the formation of a
homodimer for the initiator caspases in vitro.
Dronc is the Drosophila ortholog of the mammalian initiator
caspase-9 and is required for programmed cell death during the normal
development of fruit flies (16–18).One important downstream target of
Dronc is the effector caspase Drice, an ortholog of mammalian
caspase-3. The activation of Dronc in Drosophila cells requires Dark/
Hac-1/Dapaf-1 (19–21), the ortholog ofmammalianApaf-1. Analogous
to caspase-9, the prodomain of Dronc is responsible for interactionwith
Dark/Hac-1/Dapaf-1.2 However, in contrast to caspase-9, the prodo-
main of Dronc is cleaved off the caspase unit in Drosophila cells (22),
suggesting a different mode of activation. At present, the molecular
mechanism by which Dronc is activated remains unknown.
In this study, we report themolecularmechanism for the activation of
Dronc cleavage-induced stable dimerization. The Dronc zymogen
exists exclusively as a monomer in solution. The intrachain cleavage
triggers the preferential formation of a homodimer for the cleaved
Dronc, which exhibits a drastically elevated level of catalytic activity
when compared with themonomeric zymogen. The crystal structure of
a catalytic mutant Dronc in its zymogen form reveals the basis for cat-
alytic dormancy, an unproductive conformation in the active site.
Together, these results defined the precise molecular mechanisms by
which Dronc is activated.
EXPERIMENTAL PROCEDURES
Protein Preparation—All constructs were generated using a standard
PCR-based cloning strategy, and the identities of individual clones were
verified through double-stranded plasmid sequencing. All proteins
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were overexpressed in Escherichia coli strain BL21(DE3) either as non-
tagged protein using the vector pBB75 or as C-terminal His6-tagged
proteins using pET21b (Novagen). Proteins were purified to homoge-
neity as described (23).
Crystallization and Data Collection—Crystals of pro-domain-de-
leted Dronc (residues 136–450, C318A) were obtained by the hang-
ing-drop vapor diffusion method by mixing the complex (10 mg
ml1) with an equal volume of reservoir solution containing 100 mM
imidazole, pH 9.0, and 1.1 M ammoniummono-hydrogen phosphate.
Cubic-shaped crystals appeared after 5 days and grew to a typical
dimension of 0.2  0.2  0.2 mm3. They were in the space group
I4132 and contained one molecule in each asymmetric unit. The unit
cell dimensions are a b c 165.7 Å. Selenomethionine-derived
proteins were crystallized under a similar condition with the same
space group and similar unit cell parameters. Crystals were equili-
brated in a cryoprotectant buffer containing well buffer plus 25%
glycerol and were flash-frozen in a 170 °C nitrogen stream. The
native data were collected at the Cornell High Energy Synchrotron
Source (CHESS) beamline A1, and seleno-multiple anomalous dis-
persion data were collected at the CHESS beamline F2 and processed
using the software Denzo and Scalepack (24).
StructureDetermination—The structurewas determined bymultiple
anomalous dispersion using SOLVE (25). Seven selenium atoms per
asymmetric unit were located. These selenium positions were further
refined using MLPHARE (26). A model was built using O (27) and
refined at 2.5 Å resolution using CNS (28).
Gel Filtration Assay—Individual recombinant proteins were purified
to more than 95% homogeneity and incubated in assay buffer (25 mM
Tris, pH 8.0, 150 mMNaCl, and 2 mM dithiothreitol) for 10 min at 4 °C.
0.5 ml of the protein mixture was subjected to gel filtration analysis
(Superdex 200, Amersham Biosciences) for each run. Samples taken
from relevant fractions were applied to SDS-polyacrylamide gel electro-
phoresis (SDS-PAGE) and visualized by Coomassie Blue staining.
Dronc Activity Assay—Reactions were carried out at 22 °C in an assay
buffer containing 25 mM HEPES, pH 7.5, 150 mM NaCl, and 2 mM
dithiothreitol. Catalytically inactive DrICE zymogen (C196A) was used
as the substrate at a concentration of 100 M. Mature Dronc and
catalytically active but non-cleavable Dronc zymogen (E352A) were
purified to homogeneity and used in each reaction at 100 nM. Reaction
samples were taken out at the indicated time points and applied to
SDS-PAGE followed by Coomassie Blue staining. Similar results were
obtained under pH 6.8 and pH 8.0 as well as a variety of other ionic
strength conditions.
Drosophila Genetics and Immunocytochemistry—GMR3-Dronc-
WT, GMR-Dronc-C318S, and GMR-Dronc-E352A flies were gener-
ated by constructing wild-type (WT) Dronc, Dronc-C318S, and Dronc-
E352A into the glass multiple reporter (GMR) P element vector and
then introducing these constructs into the Drosophila germline using
standard techniques. GMR-Hid, GMR-Reaper, and GMR-Grim were
generated as described (29). Multiple lines were generated. Consis-
tently, GMR-Dronc-E352A and GMR-Dronc-C318S showed alleviated
ablated eye phenotype when compared with those of GMR-Dronc-WT
flies. Anti-Dronc antibody staining was carried out on third instar eye
discs from flies of various genotypes essentially as described (29).
Analytical Ultracentrifugation—Protein sampleswere prepared in 25
mM phosphate-buffered saline with pH 8.0 and 150 mM NaCl. All sedi-
mentation equilibrium experiments were performed with a Beckman
Optima XL-I at the Center for Analytical Ultracentrifugation of Mac-
romolecular Assemblies (theUniversity of TexasHealth Science Center
at San Antonio, Department of Biochemistry). See supplemental data
for details.
RESULTS
Dronc Undergoes Autocatalytic Cleavage—To understand how
Dronc is activated, we reconstituted an in vitro activation assay for
Dronc. The full-length WT Dronc was expressed in E. coli and purified
to homogeneity (Fig. 1A, lane 1). The purification procedures for Dronc
were carried out at 4 °C so as to maintain the WT Dronc protein in its
zymogen form. When the single-chain WT Dronc zymogen was incu-
bated at 22 °C, autocatalytic cleavage at a slow yet detectable rate was
observed as evidenced by the initial appearance of two bands below the
zymogen (Fig. 1A, lanes 2–4). Further autocatalytic cleavage resulted in
the generation of two additional products (Fig. 1A, lanes 5–7).
Analysis of the initial cleavage products by N-terminal peptide
sequencing identified the primary autocatalytic cleavage site to be after
residue Glu352, which is the last amino acid of a canonical Dronc sub-
strate sequence Thr349-Gln350-Thr351-Glu352 (349TQTE352). Although
Dronc contains two putative caspase cleavage sites 110DESD113 and
132DIVD135 between its prodomain and the caspase unit, subsequent
analysis by N-terminal peptide sequencing revealed that the additional
cleavage products were due to a secondary cleavage site after residue
Glu143 following an 140EASE143 sequence. This observation is consistent
with the finding that Dronc, in contrast to all other known caspases,
prefers substrate specificity of Glu at the P1 position (30). The acceler-
ated cleavage of Dronc was not due to other contaminating protease(s)
because no cleavage was observed for the catalytically inactive Dronc
(C318A) even after prolonged incubation (Fig. 1A, lanes 8–9).
Our studies indicated that the maturation of Dronc has two sequen-
tial cleavage events. The first and primary cleavage afterGlu352 results in
the separation of the caspase small subunit from the caspase large sub-
unit and the prodomain, whereas the second cleavage after Glu143
removes the prodomain from the catalytic core domain. The first cleav-
age after Glu352 is required for the second cleavage after Glu143 because
the mutant Dronc E352A, which eliminated the first cleavage site but
containedWT catalytic residues, remained as a single polypeptide even
after prolonged incubation (Fig. 1A, lanes 10–11).
To further characterize the autocatalytic cleavage, we incubated the
catalytically inactive Dronc C318A zymogen, which contains Glu352,
with Dronc E352A, which contains WT catalytic residues but was
unable to cleave itself due to the mutation E352A. The Dronc C318A
zymogen was cleaved after Glu352, resulting in two fragments (Fig. 1B).
This result indicates that the autocatalytic cleavage of Dronc can occur
in trans and further demonstrates that the mutant Dronc E352A is
catalytically active, albeit the level of activity remains at the basal level
(Fig. 1B).
Mature Dronc Exhibits Drastically Elevated Catalytic Activity—The
autocatalytic cleavage of Dronc likely induces its activation. To confirm
this conjecture, we reconstituted an in vitro Dronc activity assay to
compare the catalytic activity of Dronc zymogenwith that of themature
Dronc (Fig. 1C). The catalytically inactive Drice zymogen (residues
1–339, C196A) was used as a physiologically relevant substrate for
Dronc. The fact that Dronc zymogen undergoes a process of autocleav-
age (Fig. 1A) potentially complicates the interpretation of results as the
processed Dronc is expected to exhibit an elevated level of catalytic
activity. To alleviate this problem, we used the uncleavable but catalyt-
ically active Dronc variant E352A as a WT zymogen substitute.
Although the Dronc E352A zymogen exhibited a very low level of cat-
alytic activity (Fig. 1C, left panel), the mature Dronc cleaved 90% of the3 The abbreviations used are: GMR, glass multiple reporter; WT, wild-type.
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substrate within the first hour of incubation (Fig. 1C, right panel). These
experiments were performed under a condition that resembles the
physiological pH and ionic strength (see “Experimental Procedures” for
details). Similar results were obtained under other conditions (data not
shown). Thus the autocleaved Dronc exhibits a catalytic activity that is
drastically elevated over the zymogen.
Autocatalytic Cleavage of Dronc Shifts aMonomer into a Dimer—Al-
though Dronc is the functional ortholog of mammalian caspase-9, our
biochemical characterization demonstrates that they exhibit quite dif-
ferent patterns of activation. The prodomain of caspase-9 is required for
the formation of an apoptosome holoenzyme, in which the activity of
caspase-9 is allosterically regulated by Apaf-1 (8). Necessitated by this
function, there is no caspase cleavage site between the prodomain and
the caspase unit of caspase-9. Consequently, the prodomain and the
large subunit of caspase-9 are a single polypeptide chain. In contrast,
Dronc contains multiple caspase cleavage sites between its prodomain
and the caspase unit, and the prodomain of Dronc is removed after a
second autocatalytic cleavage event (Fig. 1A). These observations
strongly suggest that, in contrast to activated caspase-9 as a holoen-
zyme, the mature Dronc protein may exist as a free enzyme. These
observations further imply that Dronc may utilize a different mecha-
nism for its activation.
To investigate the activation mechanism for Dronc, we first asked
why the Dronc zymogen exhibited an extremely low level of catalytic
activity through examination of the basal state of Dronc zymogen using
gel filtration. Interestingly, the elution volume of the Dronc zymogen
(residues 1–450, C318A) corresponded to an apparent molecular mass
of 50 kDa, consistent with that of a Dronc monomer (Fig. 2A, solid
line). This observation suggests an explanation as to why the Dronc
zymogen is marginally active since an unassisted caspase monomer is
thought to be catalytically inactive due to the unproductive conforma-
tion of the active site (2).
Next, we examined the basal state of the autocleaved Dronc. Surpris-
ingly, the elution of the cleaved Dronc (residues 1–352 and 353–450,
FIGURE 1. The Dronc zymogen undergoes autocatalytic cleavage and subsequently exhibits a drastically enhanced level of catalytic activity. A, the Dronc zymogen
undergoes autocatalytic cleavages. A time course of Dronc autocatalytic cleavage was visualized by SDS-PAGE followed by Coomassie Blue staining. The cleavage products were
identified bymass spectrometry and N-terminal peptide sequencing. B, the autocatalytic cleavage can occur in trans. Although neither Dronc E352A (lane 1) nor Dronc C318 (lane 2)
was capable of autocatalytic cleavage, Dronc E352A cleaved Dronc C318A into two fragments following Glu352 (lane 3). The SDS-PAGE gel was stained by Coomassie Blue. C, mature
Dronc exhibits a significantly elevated level of catalytic activity. A time course ofDronc activitywas visualizedby SDS-PAGE followedbyCoomassie Blue staining. Catalytically inactive
Drice zymogen was used as the substrate. An equimolar amount of Dronc zymogen (indicated by double asterisks) or mature Dronc (indicated by the single asterisk) was incubated
with the substrate. Molecular weight markers (MWM) are indicated to the left.
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C318A) was shifted to earlier fractions (Fig. 2A, dotted line), with the
elution volume corresponding to an apparent molecular mass of100
kDa. This observation strongly suggests that the primary autocatalytic
cleavage induces the formation of a stable Dronc homodimer. To defin-
itively confirm this finding, we performed analytical ultracentrifugation
experiments (Fig. 2B and Supplemental data). As anticipated, the single-
chain Dronc zymogen (residues 136–450, C318A) existed exclusively
as a monomer in solution, with a fitted molecular mass of 34.8  0.3
kDa. In contrast, the two-chain Dronc (residues 136–352 and 353–450,
C318A) existed primarily as a stable homodimer in solution, with a
dissociation constant (Kd) of0.27 M. Thus Dronc activation appears
to employ an interesting mechanism; the cleavage after Glu352 triggers
the transition from an inactive monomer for the Dronc zymogen to a
catalytically active dimer for the cleaved Dronc.
Structure of Dronc Zymogen Reveals an Unproductive Conformation
in the Active Site—To elucidate the molecular mechanism by which
Dronc zymogen remains catalytically inactive, we expressed, purified,
and crystallized a prodomain-deleted Dronc zymogen (residues 136–
450, C318A). The structure was determined bymultiwavelength anom-
alous dispersion and refined to 2.5 Å resolution (Table 1 and Fig. 3A).
Each asymmetric unit contains one monomer of the Dronc zymogen.
Similar to other known caspases, the Dronc zymogen contains a cen-
tral six-stranded  sheet, flanked on each side by three  helices (Fig. 3,
B and C). In contrast to other caspases, the Dronc zymogen exhibits a
number of unique structural features. For example, a 39-residue frag-
ment (residues 158–196) at theN terminus forms an extended and rigid
surface loop that zigzags across one side of the zymogen (Fig. 3, A and
B). The fact that autocleavage after Glu352 leads to formation of a Dronc
dimer suggests two possibilities; either the L2 loop interferes with dimer
formation in the zymogen, or the cleaved L2 loop significantly strength-
ens dimer formation in the processed Dronc. In the crystals, the bulk of
the L2 loop is disordered and does not allow a direct examination of the
first possibility.
Four surface loops, L1, L2, L3, and L4, emanate from the structural
core, forming a potential active site (Fig. 3B). The L2 loop appears to be
highly flexible as the electron density after residue Ala318 becomes dis-
continuous. Loops L3 and L4 also exhibit some flexibility, as judged by
their high temperature factors in the crystals. These structural observa-
tions are not surprising because these surface loops are completely
exposed to solvent. Previous studies on caspase-7 showed that the active
site loops only become ordered upon activation cleavage and binding to
substrate or inhibitors (4).
Structural analysis reveals that the active site of the Dronc zymogen
exists in an unproductive conformation (Fig. 3D). In contrast to the
active site conformation of the activated, inhibitor-free caspase-7 (Fig.
FIGURE 2.AutocleavageofDronc shifts a constitutivemonomer into a stable dimer.A, theDronc zymogen appeared to be amonomer, but the autocleavedDroncwas primarily
a dimer. Shown here is a superposition of the gel filtration chromatograms for the Dronc zymogen (solid line) and the autocleaved Dronc (dashed line). Both Dronc protein samples
contained amutation C318A on the catalytic residue Cys318 so as to eliminate a potential problem of protein degradation. The autocleaved Dronc was obtained by co-expression of
the large (residues 1–352) and small (residues 353–450) subunits. Peak fractions were visualized by SDS-PAGE followed by Coomassie Blue staining (right panels). B, the Dronc
zymogen exists exclusively as a monomer, but the autocleaved Dronc is primarily a dimer with a dissociation constant of 0.27 M. These results were obtained from the analytical
ultracentrifugation experiments (see Supplemental data).MW, molecular weight.
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3, D and E) or the activated, inhibitor-bound caspase-9 (Fig. 3F), the
substrate-binding groove in Dronc zymogen is absent in this conforma-
tion. Previous studies showed that, to form a productive active site con-
formation for a caspase, the L2 loop, which contains the catalytic resi-
due, must interact with other structural elements such as the L2 loop
from the adjacent monomer (Fig. 3, E and F). However, the monomeric
Dronc zymogen lacks such supporting elements from an adjacent mon-
omer. These structural features do not support substrate binding or
catalysis and are consistent with the biochemical observation that the
Dronc zymogen remains catalytically inactive.
Uncleavable Dronc Zymogen Is Dominant Negative in Vivo—Our
biochemical characterization demonstrates that the Dronc zymogen is
constitutivelymonomeric in solution and catalytically inactive due to an
unproductive conformation at the active site. The autocleavage after
Glu352 favors the formation of a Dronc dimer, which presumably results
in the alteration of the unproductive active site conformation. In vivo,
the autoactivation process of Dronc is likely facilitated by Dark/Hac-1/
Dapaf-1 as Dronc activation in Drosophila cells requires Dark/Hac-1/
Dapaf-1 (19–21). These analyses predict that an uncleavable Dronc
zymogen E352A will likely act in a dominant negative fashion in vivo as
this protein may compete with WT Dronc zymogen for binding to
Dark/Hac-1/Dapaf-1.
To corroborate our biochemical and structural findings, we gener-
ated transgenic flies overexpressing theWTDronc, the catalyticmutant
Dronc (C318S), or the uncleavable Dronc (E352A) under the eye-spe-
cificGMRpromoter. Indeed, although overexpression of theWTDronc
caused an ablated eye phenotype (Fig. 4A), overexpression of the cata-
lyticmutantDronc (Fig. 4B) or the uncleavableDronc (Fig. 4C) had little
impact on the eyes, suggesting that these Dronc variants were unable to
become activated in vivo. The pro-apoptotic proteins Reaper, Hid, and
Grim (RHG) function by antagonizing the activity of DIAP1 (31). Over-
expression of the pro-apoptotic genes Reaper, Grim, and Hid led to
induction of cell death and ablated eye phenotypes (Fig. 4, D–F). Co-
expression of the Dronc catalytic mutant (C318S) (Fig. 4, G–I) or the
uncleavable Dronc (E352A) (Fig. 4, J–L) partially suppressed the ablated
eye phenotype. In Drosophila, continuous activity of Dark/Hac-1/
Dapaf-1 is required for normal apoptosis (32). Presumably, the catalyt-
ically inactive Dronc zymogen or the uncleavable Dronc was able to
bind to and saturate all available Dark/Hac-1/Dapaf-1 protein and thus
had a negative impact on the autoactivation ofWTDronc proteinmedi-
ated by Dark/Hac-1/Dapaf-1.
DISCUSSION
Previous studies on the activation of mammalian initiator caspases
have revealed significant insights into the mechanisms. Zymogen of
both caspase-8 and caspase-2 was found to exist mainly as a monomer
by gel filtration (13–15). In contrast, the autocleaved wild-type
caspase-8 exists in an equilibrium betweenmonomers and dimers, with
a dissociation constant of 50 M (14). The processed wild-type
caspase-2 also preferentially formed homodimers (15). These findings
strongly argue that dimerization is a crucial factor for the activation of
caspase-8 and caspase-2 and that the autocatalytic cleavage in these
mammalian initiator caspases plays an important role for their
activation.
In this study,we investigate the activationmechanism for theDrosophila
initiator caspase Dronc. We demonstrate that the Dronc zymogen exists
exclusively as amonomer in solutionand formsa stabledimer following the
primary autocatalytic cleavage after Glu352. A cleavage mutant Dronc
(E352A) does not undergo autocatalytic cleavage and remains a monomer
in solution. The structure of the Dronc zymogen, representing the first
structure of an uncleaved initiator caspase zymogen, reveals an unproduc-
tive active site conformation. At present, we do not yet have a structure of
the activated, dimeric Dronc, which is expected to reveal the precise con-
formation of the active site. Nonetheless, previous studies on dimeric
caspases suggest that the active site of one Dronc monomer is likely stabi-
lized by the adjacent monomer through the provision of a critical surface
loop (L2) (33). Our results demonstrate that the autocatalytic cleavage
after Glu352 of Dronc greatly facilitates its dimerization, which is essential
for its catalytic activity.
If Dronc zymogen exists exclusively as a monomer in solution, how
can autocatalytic cleavage occur? There are two possibilities. One is that
TABLE 1
Summary of crystallographic analysis
Native (Dronc) Peak (Se1) Inflection (Se2) Remote (Se3)
Data sets
Beamline CHESS-A1 CHESS-F2 CHESS-F2 CHESS-F2
Space group I4132 I4132 I4132 I4132
Wavelength (Å) 1.1000 0.9793 0.9791 0.964
Resolution (Å) 99–2.5 99–3.1 99–3.1 99–3.1
Unique reflections 12,899 6,540 6,534 6,553
Completeness (%) (outer shell) 99.7 (100.0) 94.4 (96.7) 94.5 (97.0) 94.6 (96.9)
Rsyma (outer shell) 0.055 (0.33) 0.107 (0.43) 0.093 (0.40) 0.097 (0.42)
Data redundancy 26.0 19.2 19.4 19.4
Average I/ anomalous difference (%) 61.4 (15.6) 30.7 (8.9) 32.1 (9.1) 31.3 (8.9)
Refinement statistics
Resolution range (Å) 20–2.5
Number of reflections (F 0) 12,855
Total number of atoms (water) 2,228 (201)
Completeness of data 99.6%
R-factorb (R-free) 0.269 (0.222)
r.m.s.d.c
Bond (Å) 0.006
Angle (deg.) 1.43
Ramachandran plot
Most favored 82.5%
Additionally allowed 16.9%
Generously allowed 0.5%
Disallowed 0.0%
a Rsym hiIh,i Ih/hiIh,i, where Ih is the mean intensity of the i observations of symmetry-related reflections of h.
b R Fobs Fcalc/Fobs, where Fobs FP, and Fcalc is the calculated protein structure factor from the atomic model (Rfree was calculated with 5% of the reflections).
c r.m.s.d. (root-mean-square deviation) in bond lengths and angles are the deviations from ideal values.
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FIGURE 3. Structure of theDronc zymogen reveals amolecular basis for the lack of catalytic activity.A, a representative portion of the electron density 2Fo Fcmap, contoured
at 1.1  and colored cyan, was shown in stereo around amino acid residues 158–230. B, overall structure of the Dronc zymogen in two perpendicular views. The structural core of
Dronc zymogen is shown in brown, with the active site loops highlighted inmagenta. The extended N-terminal fragment (residues 158–196) is colored cyan. The four loops defining
the potential catalytic site are labeled. C, sequence alignment among Dronc, caspase-9 (Casp-9), and caspase-7 (Casp-7). Because the N-terminal fragment of Dronc exhibits no
apparent sequence similarity with caspase-9 or caspase-7, only residues 185–450 of Dronc are shown here. The secondary structural elements of the Dronc zymogen are indicated
above the sequences. Conserved residues are colored yellow. D, the appropriate substrate-binding groove is absent in the Dronc zymogen. When compared with the activated,
inhibitor-free caspase-7 (middle panel), the Dronc zymogen does not have an appropriate substrate-binding groove (left panel). The active site of the caspase-7 zymogen is shown
here as a control (right panel). E, comparison of the conformations of the active site loops amongDronc zymogen, the activated inhibitor-free caspase-7, and the caspase-7 zymogen.
The green dotted line represents the L2 loop in the activated inhibitor-bound caspase-7. F, the active site conformation of the Dronc zymogen is quite different from that of the
inhibitor-bound caspase-9 (inhibitor omitted for clarity). The active site conformationof caspase-9 is critically supportedby the L2 loop,which is providedby the adjacentmonomer.
However, in Dronc zymogen, the monomeric and uncleaved nature prevents the provision of the L2 loop.
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the monomeric zymogen can associate transiently into dimers, as sug-
gested for the initiator caspase-2 (15). Then the transiently dimerized
Dronc zymogens process each other in trans. The other possibility is
that the monomeric Dronc zymogen can exhibit a very low level of
catalytic activity for its own intramolecular cleavage. Although our cur-
rent study does not allow differentiation of these two scenarios, the
experimental evidence indicated that the autocatalytic cleavage of
Dronc can occur in trans, suggesting that the cleavage might be a result
of transient dimerization. However, our data are merely suggestive, and
we do not know whether the autocatalytic cleavage can also occur
intramolecularly. Nonetheless, our results unambiguously show that
the autocatalytic cleavage greatly facilitates the formation of a
homodimer for Dronc.
Although Dronc is the functional homolog of the mammalian
caspase-9, their activationmechanisms appear to be quite different (Fig.
5). For caspase-9, the intrachain cleavage is not necessary for its activa-
tion as the fully processed caspase-9 in isolation is only marginally
active, much the same way as the unprocessed caspase-9 zymogen (8,
10, 34). Rather, association with the apoptosome leads to a dramatic
increase (up to 2000-fold) for the catalytic activity of the processed as
well as the unprocessed caspase-9 (8, 10). Necessitated by association
with apoptosome, the prodomain of caspase-9 remains covalently
linked to the large subunit of the caspase unit. In contrast to caspase-9,
the free, processed Dronc exhibits a catalytic activity that is several
orders of magnitude higher than the Dronc zymogen (Fig. 1C). The
extent of activity improvement is reminiscent of catalytic activation for
other caspases (35). Thus the processed, freeDronc likely represents the
fully activated state. This notion is supported by the observation that the
prodomain of Dronc, which is responsible for binding to Dark/Hac-1/
Dapaf-1, is removed from the caspase unit in the mature enzyme. In
addition, the presence of recombinant Dark/Hac-1/Dapaf-1 protein
does not enhance the catalytic activity of the mature Dronc.2
FIGURE 4.Uncleavable Dronc zymogen is domi-
nant negative in vivo. Genotypes are as follows:
GMR-Dronc/ (A), GMR-Dronc-C318S/ (B), GMR-
Dronc-E352A/ (C), GMR-Rpr/ (D), GMR-Grim/
(E), GMR-Hid/ (F), GMR-Rpr/GMR-Dronc-C318S (G),
GMR-Grim/GMR-Dronc-C318S (H), GMR-Hid/GMR-
Dronc-C318S (I), GMR-Rpr/GMR-Dronc-E352A (J),
GMR-Grim/GMR-Dronc-E352A (K), and GMR-Hid/
GMR-Dronc-E352A (L).
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Isolated caspase-9 exists constitutively as a monomer in solution,
both in its zymogen state and in the autocleaved form (9) (Fig. 5).
Caspase-3 or caspase-7, on the other hand, exists constitutively as a
homodimer in solution, both in its zymogen form and in the cleaved,
activated state (Fig. 5). In contrast to both caspase-9 and caspase-3,
Dronc exists exclusively as a monomer in the zymogen state and forms
a stable dimer with a dissociation constant of 0.27 M following the
primary autocatalytic cleavage. The mammalian initiator caspases,
caspase-8 and caspase-2, exhibit an increased preference for the forma-
tion of homodimer following the autocatalytic cleavage. In this regard,
the activation of the initiator caspases, Dronc in Drosophila and
caspase-8/-2 inmammals, incorporates a feature reminiscent of effector
caspases (Fig. 5). In amore general sense, our study reveals another level
of complexity in the activation of caspases and suggests diverse mech-
anisms for the activation of initiator caspases.
It should be pointed out that the model presented (Fig. 5) only
highlights certain biochemical aspects of caspase activation. There
are a number of other important considerations to caspase activation
in vivo. For example, the activation of Dronc in Drosophila cells
requires the presence of Dark/Hac-1/Dapaf-1 (19–21,32). A recent
study showed that the Dark/Hac-1/Dapaf-1 protein forms a double-
donut-shaped apoptosome, with each donut ring comprising eight
molecules of Dark/Hac-1/Dapaf-1 (36). The Dark/Hac-1/Dapaf-1
apoptosomemay greatly facilitate the recruitment and the activation
of the Dronc zymogen by enhancing its dimerization. However, the
mechanism by which the Dark/Hac-1/Dapaf-1 apoptosome activates
the Dronc zymogen is likely to be different from that by which the
Apaf-1 apoptosome activates caspase-9. The detailed activation
mechanisms for initiator caspases remain to be investigated by bio-
chemistry and structural biology.
Acknowledgments—We thank Lana Walsh for beam time at CHESS and
Michael Becker for beam time at BrookhavenNational Laboratory. The devel-
opment of the UltraScan Software is supported by the National Science Foun-
dation through Grant DBI-9974819 to B. Demeler.
REFERENCES
1. Thornberry, N. A., and Lazebnik, Y. (1998) Science 281, 1312–1316
2. Riedl, S. J., and Shi, Y. (2004) Nat. Rev. Mol. Cell Biol. 5, 897–907
3. Budihardjo, I., Oliver, H., Lutter, M., Luo, X., and Wang, X. (1999) Annu. Rev. Cell
Dev. Biol. 15, 269–290
4. Chai, J., Wu, Q., Shiozaki, E., Srinivasula, S. M., Alnemri, E. S., and Shi, Y. (2001) Cell
107, 399–407
5. Riedl, S. J., Fuentes-Prior, P., Renatus, M., Kairies, N., Krapp, S., Huber, R., Savesen,
G. S., and Bode, W. (2001) Proc. Natl. Acad. Sci. U. S. A. 98, 14790–14795
6. Shi, Y. (2004) Cell 117, 855–858
7. Wang, X. (2001) Genes Dev. 15, 2922–2933
8. Rodriguez, J., and Lazebnik, Y. (1999) Genes Dev. 13, 3179–3184
9. Shiozaki, E. N., Chai, J., Rigotti, D. J., Riedl, S. J., Li, P., Srinivasula, S.M., Alnemri, E. S.,
Fairman, R., and Shi, Y. (2003)Mol. Cell 11, 519–527
10. Srinivasula, S. M., Saleh, A., Hedge, R., Datta, P., Shiozaki, E., Chai, J., Robbins, P. D.,
Fernandes-Alnemri, T., Shi, Y., and Alnemri, E. S. (2001) Nature 409, 112–116
11. Renatus,M., Stennicke, H. R., Scott, F. L., Liddington, R. C., and Salvesen, G. S. (2001)
Proc. Natl. Acad. Sci. U. S. A. 98, 14250–14255
12. Chao, Y., Shiozaki, E. N., Srinivasula, S. M., Rigotti, D. J., Fairman, R., and Shi, Y.
(2005) PLoS Biol. 3, e183
13. Boatright, K. M., Renatus, M., Scott, F. L., Sperandio, S., Shin, H., Pedersen, I. M.,
Ricci, J. E., Edris, W. A., Sutherlin, D. P., Green, D. R., and Salvesen, G. S. (2003)Mol.
Cell 11, 529–541
14. Donepudi, M., Mac Sweeney, A., Briand, C., and Grutter, M. G. (2003)Mol. Cell 11,
543–549
15. Baliga, B. C., Read, S. H., and Kumar, S. (2004) Cell Death Differ. 11, 1234–1241
16. Dorstyn, L., Colussi, P. A., Quinn, L. M., Richardson, H., and Kumar, S. (1999) Proc.
Natl. Acad. Sci. U. S. A. 96, 4307–4312
17. Chew, S. K., Akdemir, F., Chen, P., Lu,W. J.,Mills, K., Daish, T., Kumar, S., Rodriguez,
A., and Abrams, J. M. (2004) Dev. Cell 7, 897–907
18. Daish, T. J., Mills, K., and Kumar, S. (2004) Dev. Cell 7, 909–915
19. Kanuka,H., Sawamoto, K., Inohara, N.,Matsuno, K., Okano,H., andMiura,M. (1999)
Mol. Cell 4, 757–769
20. Zhou, L., Song, Z., Tittel, J., and Steller, H. (1999)Mol. Cell 4, 745–755
21. Rodriguez, A., Oliver, H., Zou, H., Chen, P., Wang, X., and Abrams, J. M. (1999)Nat.
Cell Biol. 1, 272–279
22. Muro, I., Monser, K., and Clem, R. J. (2004) J. Cell Sci. 117, 5035–5041
23. Yan, N.,Wu, J.-W., Huh, J. R., Chai, J., Li,W., Hay, B. A., and Shi, Y. (2004)Nat. Struct.
Mol. Biol. 11, 420–428
24. Otwinowski, Z., and Minor, W. (1997)Methods Enzymol. 276, 307–326
25. Terwilliger, T. C., and Berendzen, J. (1999) Acta Crystallogr. Sect. D Biol. Crystallogr.
55, 849–861
26. Collaborative Computational Project, N. (1994) Acta Crystallogr. Sect. D Biol. Crys-
tallogr. 50, 760–763
27. Jones, T. A., Zou, J.-Y., Cowan, S.W., andKjeldgaard,M. (1991)ActaCrystallogr. Sect.
A 47, 110–119
28. Brunger, A. T., Adams, P. D., Clore, G.M., Delano,W. L., Gros, P., Grosse-Kunstleve,
R. W., Jiang, J. S., Kuszewski, J., Nilges, M., Pannu, N. S., Read, R. J., Rice, L. M.,
Simonson, T., andWarren, G. L. (1998)Acta Crystallogr. Sect. D Biol. Crystallogr. 54,
905–921
29. Yoo, S. J., Huh, J. R.,Muro, I., Yu,H.,Wang, L.,Wang, S. L., Feldman, R.M., Clem, R. J.,
Muller, H. A., and Hay, B. A. (2002) Nat. Cell Biol. 4, 416–424
30. Hawkins, C. J., Yoo, S. J., Peterson, E. P., Wang, S. L., Vernooy, S. Y., and Hay, B. A.
(2000) J. Biol. Chem. 275, 27084–27093
31. Hay, B. A., Huh, J. R., and Guo, M. (2004) Nat. Rev. Genet. 5, 911–922
32. Rodriguez, A., Chen, P., Oliver, H., and Abrams, J. M. (2002) EMBO J. 21, 2189–2197
33. Shi, Y. (2002)Mol. Cell 9, 459–470
34. Stennicke,H. R., Deveraux,Q. L., Humke, E.W., Reed, J. C., Dixit, V.M., and Salvesen,
G. S. (1999) J. Biol. Chem. 274, 8359–8362
35. Salvesen, G. S., andDixit, V.M. (1999) Proc. Natl. Acad. Sci. U. S. A. 96, 10964–10967
36. Yu, X.,Wang, L., Acehan, D.,Wang, X., andAkey, C. (2006) J.Mol. Biol. 355, 577–589
FIGURE 5. A comparison of Dronc activation with activation of other caspases. This
comparison reveals that Dronc exhibits features of both initiator and effector caspases.
The inactive zymogens and the activated caspases are colored green and orange, respec-
tively. The thick and thin arrows denote the primary and secondary cleavage events,
respectively.
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